Robert A. Hauser And NotCanada

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
000245	Olivier Rascol [France] ; Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Cheryl J. Fitzer-Attas [États-Unis] ; Yulia Sidi [Israël] ; Victor Abler [États-Unis] ; C Warren Olanow [États-Unis]	Long-term effects of rasagiline and the natural history of treated Parkinson's disease.
000315	Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis]	Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
000535	Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis]	Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
000923	Robert A. Hauser [États-Unis] ; Mark Forrest Gordon [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Paolo Barone [Italie] ; Anthony H. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Catherine Debieuvre [France] ; Mandy Fr Dorf [Allemagne]	Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
000949	John P. Seibyl [Oman] ; Andreas Kupsch [Allemagne] ; Jan Booij [Pays-Bas] ; Donald G. Grosset [Royaume-Uni] ; Durval C. Costa [Portugal] ; Robert A. Hauser [États-Unis] ; Jacques Darcourt [France] ; Nin Bajaj [Royaume-Uni] ; Zuzana Walker [Royaume-Uni] ; Kenneth Marek [États-Unis] ; Ian Mckeith [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; Klaus Tatsch [Allemagne] ; Eduardo Tolosa [Espagne] ; Rudi A. Dierckx ; Igor D. Grachev [États-Unis]	Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
001B50	Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]	Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
001C04	Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]	Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
002800	Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis]	Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (Tesofensine) in early parkinson's disease
005961	Robert A. Hauser [États-Unis] ; Hermann Russ ; Doris-Anita Haeger ; Michel Bruguiere-Fontenille ; Thomas Müller ; Gregor K. Wenning	Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024